Streetbeat News

Products Services

AMGN

The FDA has granted full approval for Amgen's BLINCYTO to treat minimal residual disease-positive B-cell precursor acute lymphoblastic leukemia. The approval is based on additional data from two Phase 3 studies and converts BLINCYTO's accelerated approval to a full approval.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 1:01 pm

EXAS

Exact Sciences Corp (NASDAQ:EXAS) shares are trading higher after the company announced positive top-line results from its BLUE-C study, demonstrating 94% sensitivity for colorectal cancer at 91% specificity. The company also announced collaborations with Broad Institute of MIT and Harvard and Baylor Scott & White to improve patient care by increasing access to genomic information.

Portfolio Pulse from Adam Eckert

June 21, 2023 | 12:59 pm

CDIO

Cardio Diagnostics announced the nationwide launch of PrecisionCHD, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2023 | 12:54 pm

OCEA

Ocean Biomedical's shares are trading higher following a share price target increase to $17.63 by Fundamental Research Corp, based on positive results from an independent study on glioblastoma tumor suppression, recent patents, and financing.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2023 | 12:51 pm

STKL

SunOpta's subsidiary, Sunrise Growers Inc., has issued a voluntary recall of specific frozen fruit products due to potential contamination by Listeria monocytogenes. The recall is linked to pineapple provided by a third-party supplier.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 12:50 pm

CNDT

Conduent Incorporated (NASDAQ:CNDT) has opened its first office in Thessaloniki, Greece, focusing on customer experience management (CXM) services. The company has hired nearly 100 bilingual and multilingual CXM agents, providing German language customer care services for a leading European telecom company.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 12:46 pm

AHI

CMMB

OCTO

AHI signed a letter of intent with UAE-based e-Script Medicine Management Company Pharmak Direct. Eightco Holdings Inc. (OCTO) raised its revenue guidance to $73 million for FY2023. Chemomab Therapeutics (CMMB) reported positive data from a secondary analysis of a Phase 2a liver fibrosis trial in NASH patients at EASL 2023.

Portfolio Pulse from ryanfaloona@benzinga.com

June 21, 2023 | 12:41 pm

COIN

MARA

RIOT

Crypto-related stocks Coinbase, Marathon Digital, and Riot Platforms are rising amid a surge in the crypto market, driven by positive developments such as the launch of EDX Markets and BlackRock's application for the first spot Bitcoin ETF in the U.S.

Portfolio Pulse from Adam Eckert

June 21, 2023 | 12:41 pm

GSK

GSK announced new data from the AReSVi-006 phase 3 trial, showing that a single dose of Arexvy vaccine is efficacious against RSV-LRTD and severe LRTD in adults aged 60 years and older over two full RSV seasons. The trial also found that revaccination after 12 months does not appear to confer additional benefit for the overall population.

Portfolio Pulse from Vandana Singh

June 21, 2023 | 12:40 pm

TSLA

Elon Musk, CEO of Tesla Inc, met with Indian Prime Minister Narendra Modi and expressed admiration for him, showing enthusiasm about India's future. Musk is optimistic about Tesla's entry into India and plans to visit the country next year. He also hopes to bring his Starlink Internet service to rural areas in India.

Portfolio Pulse from Shomik Sen Bhattacharjee

June 21, 2023 | 12:40 pm